In the BioHarmony Drug Report Database

"Preview" Icon

Ganirelix

Ganirelix Acetate, Orgalutran (ganirelix acetate) is a protein pharmaceutical. Ganirelix acetate was first approved as Ganirelix Acetate on 1999-07-29. It is used to treat ovarian hyperstimulation syndrome in the USA. It has been approved in Europe to treat assisted reproductive techniques and ovulation induction. It is known to target gonadotropin-releasing hormone receptor.

 

Trade Name

 

Orgalutran
 

Common Name

 

ganirelix acetate
 

ChEMBL ID

 

CHEMBL1251
 

Indication

 

assisted reproductive techniques, ovarian hyperstimulation syndrome, ovulation induction
 

Drug Class

 

Hormone-release inhibiting peptides

Image (chem structure or protein)

Ganirelix structure rendering